Health CarePharmaceuticals & Biotechnology
  • Price (INR)575.75
  • Today's Change-1.85 / -0.32%
  • Shares traded1.20m
  • 1 Year change-1.55%
  • Beta0.4789
Data delayed at least 15 minutes, as of Jan 23 2017 10:29 GMT.
More ▼

Events & Activity

  • CIPLA:NSI price moved over +1.02% to 586.70
  • CIPLA:NSI trading volume exceeds daily average by +15.00%
  • CIPLA:NSI price falls below 15-day moving average to 576.00 at 12:31 GMT
  • CIPLA:NSI price falls below 15-day moving average to 577.70 at 15:15 GMT
  • CIPLA:NSI price rises above 15-day moving average to 579.00 at 12:32 GMT

Key statistics

On Monday, Cipla Ltd (CIPLA:NSI) closed at 575.75, -6.81% below its 52-week high of 617.80, set on Sep 23, 2016.
52-week range
457.45May 25 2016617.80Sep 23 2016
Previous close577.60
Average volume754.13k
Shares outstanding804.41m
Free float513.63m
P/E (TTM)55.75
Market cap464.63bn INR
EPS (TTM)10.36 INR
Annual div (ADY)2.00 INR
Annual div yield (ADY)0.35%
Div ex-dateSep 12 2016
Div pay-dateOct 28 2016
Data delayed at least 15 minutes, as of Jan 23 2017 10:29 GMT.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.